Paper12940779
Hepatic 'stem cell' malignancies in adults: four cases.
Theise ND and 8 others. Histopathology, 2003. Cited by 156 papers, by iCite.
Cite this record
ConductScience Library. Hepatic 'stem cell' malignancies in adults: four cases. Papers, record 12940779. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12940779
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Transformation, Neoplastic | Major topic |
| Hepatitis, Chronic | Major topic |
| Liver Neoplasms | Major topic |
| Stem Cells | Major topic |
| Aged | |
| Carcinoma, Hepatocellular | |
| Cholangiocarcinoma | |
| Female | |
| Humans | |
| Immunohistochemistry | |
| Male | |
| Middle Aged |
Source PubMed
Cited by74
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 156 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41987864 | Update on the clinical features, treatment and histogenesis of combined hepatocellular-cholangiocarcinoma. | Oncol Lett | 2026 | https://conductscience.org/library/papers/41987864 | PubMed |
| 40502515 | Liver transplantation for combined hepatocellular cholangiocarcinoma: Current evidence, selection criteria, and therapeutic controversies. | World J Gastrointest Surg | 2025 | https://conductscience.org/library/papers/40502515 | PubMed |
| 38818284 | Combined hepatocellular cholangiocarcinoma: A clinicopathological update. | World J Hepatol | 2024 | https://conductscience.org/library/papers/38818284 | PubMed |
| 37761023 | Advances in Histological and Molecular Classification of Hepatocellular Carcinoma. | Biomedicines | 2023 | https://conductscience.org/library/papers/37761023 | PubMed |
| 36672443 | Pathology of Combined Hepatocellular Carcinoma-Cholangiocarcinoma: An Update. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36672443 | PubMed |
| 36009374 | Combined Hepatocellular-Cholangiocarcinoma: An Update on Pathology and Diagnostic Approach. | Biomedicines | 2022 | https://conductscience.org/library/papers/36009374 | PubMed |
| 34012943 | Postresection prognosis of combined hepatocellular carcinoma-cholangiocarcinoma according to the 2010 World Health Organization classification: single-center experience of 168 patients. | Ann Surg Treat Res | 2021 | https://conductscience.org/library/papers/34012943 | PubMed |
| 32729276 | Combined Hepatocellular-Cholangiocarcinoma: Changes in the 2019 World Health Organization Histological Classification System and Potential Impact on Imaging-Based Diagnosis. | Korean J Radiol | 2020 | https://conductscience.org/library/papers/32729276 | PubMed |
| 32509081 | A case of small hepatocellular carcinoma with malignant ductular reaction. | Int J Clin Exp Pathol | 2020 | https://conductscience.org/library/papers/32509081 | PubMed |
| 32190288 | Murine hepatoblast-derived liver tumors resembling human combined hepatocellular-cholangiocarcinoma with stem cell features. | Cell Biosci | 2020 | https://conductscience.org/library/papers/32190288 | PubMed |
| 31569444 | Mitogen-Activated Protein Kinases (MAPKs) and Cholangiocarcinoma: The Missing Link. | Cells | 2019 | https://conductscience.org/library/papers/31569444 | PubMed |
| 31011252 | Update on hepatocellular carcinoma: Pathologists' review. | World J Gastroenterol | 2019 | https://conductscience.org/library/papers/31011252 | PubMed |
| 30813932 | Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trends. | World J Surg Oncol | 2019 | https://conductscience.org/library/papers/30813932 | PubMed |
| 30717258 | YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/30717258 | PubMed |
| 30643759 | Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions. | J Hepatocell Carcinoma | 2019 | https://conductscience.org/library/papers/30643759 | PubMed |
| 30191007 | Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress. | Hepat Oncol | 2015 | https://conductscience.org/library/papers/30191007 | PubMed |
| 30190944 | Insight into hepatocellular carcinoma biology with gadoxetate disodium-enhanced MRI. | Hepat Oncol | 2014 | https://conductscience.org/library/papers/30190944 | PubMed |
| 30148147 | Negative impact of hepatitis B surface seroclearance on prognosis of hepatitis B-related primary liver cancer. | World J Clin Cases | 2018 | https://conductscience.org/library/papers/30148147 | PubMed |
| 30119698 | Synchronous double primary hepatic cancer consisting of hepatocellular carcinoma and cholangiolocellular carcinoma: a case report. | J Med Case Rep | 2018 | https://conductscience.org/library/papers/30119698 | PubMed |
| 29360137 | cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation. | Hepatology | 2018 | https://conductscience.org/library/papers/29360137 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12940779
GET https://conductscience.org/api/papers/v1/12940779/cited_by?page=2